Trial intelligence / Profile preview

ASCCOVID19: Cardiac Screening in Athletes Post-COVID-19

NCT04936503Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Jun 2020
Primary completion
Mar 2021
Countries
1
01

Overview

Open-label trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Presence of rhythmic risk markers by the questionnaire at 0 days, Evaluation by resting ECG of rhythmic risk marker: repolarization disorders at 0 days and 2 more. Started Jun 2020; status: completed.

Beyond the preview

Go deeper on NCT04936503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04936503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call